Showing results (51-60 of 213) with videos related to
Sort By:
Pageof 22
Revue Medicale De Bruxelles|December 9, 2004
[Gabapentin (Neurontin) and cancer pain: a pilot study]D A Lossignol, B Plehiers, J J BodySupportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 7, 2000
Decreased efficacy of bisphosphonates for recurrences of tumor-induced hypercalcemiaJ J Body, I Louviaux, J C DumonJournal of Surgical Oncology|October 1, 1996
Tumor-induced hypercalcemia in a patient with extensive soft tissue sarcoma: effects of bisphosphonate therapy and surgeryV Oleffe, J C Dumon, J J BodyBone and Mineral|December 1, 1991
Efficacy and safety of the bisphosphonate tiludronate for the treatment of tumor-associated hypercalcemiaJ C Dumon, A Magritte, J J BodySupportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 8, 1998
Constipation in advanced cancer patientsI Mancini, E BrueraInternational Journal of Cancer|June 4, 1998
Establishment and characterization of three new breast-cancer cell linesB Siwek, D Larsimont, M Lacroix, et al.Revue Medicale De Bruxelles|June 5, 2001
[Terminal medical interventions: psychosocial, medical, ethical and legal aspects]M Englert, A Ronson, D Lossignol, et al.The Journal of Clinical Endocrinology and Metabolism|January 1, 1989
Effects of estrogens and calcium on calcitonin secretion in postmenopausal womenJ J Body, M Struelens, A Borkowski, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 1, 1986
Serum osteocalcin (BGP) in tumor-associated hypercalcemiaJ J Body, A Cleeren, M Pot, et al.The Journal of Clinical Endocrinology and Metabolism|June 1, 1992
Recovery of parathyroid hormone secretion during correction of tumor-associated hypercalcemiaJ J Body, J C Dumon, F Seraj, et al.Pageof 22